Profil
Rémi Delansorne served as the Chief Executive Officer & Director at Hybrigenics SA from 2007 to 2017.
Prior to that, he worked at Hybrigenics SA from 2004 to 2020.
He also worked as the Head-Diabetes Research at Merck Serono Ltd. Dr. Delansorne holds a doctorate degree from Université Pierre et Marie Curie and a doctorate degree from École Nationale Vétérinaire d'Alfort.
Anciens postes connus de Rémi Delansorne
| Sociétés | Poste | Fin |
|---|---|---|
| ATON | Directeur Général | 12/03/2020 |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Corporate Officer/Principal | - |
Formation de Rémi Delansorne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Hybrigenics SA
Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
École Nationale Vétérinaire d'Alfort
École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















